KalVista Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsKalVista Pharmaceuticals

KalVista Pharmaceuticals(KALV)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Annual sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

hereditary angioedema types i and ii

,

hereditary angioedemas

,

Hyaluronate sodium

healthy volunteers/patients

,

chronic renal insufficiency

,

kidney diseases

,

,

type 2 diabetes mellitus

,

diabetes mellitus

,

amyotrophic lateral sclerosis

,

motor neuron disease

,

non-small-cell lung carcinoma

,

hepatocellular carcinoma

,

liver neoplasms

,

renal cell carcinoma

,

breast neoplasms

,

triple negative breast neoplasms

,

,

colorectal neoplasms

,

neoplasm metastasis

,

,

malignant mesothelioma

Bos taurus adrenal cortex corticosteroids

,

atrial fibrillation

,

,

coronary artery disease

,

,

chronic renal insufficiency

,

chronic kidney failure

,

kidney transplantation

,

pulmonary fibrosis

,

secondary hyperparathyroidism

,

physiological stress

,

hypersensitivity

healthy volunteers/patients

,

von willebrand diseases

,

thrombotic thrombocytopenic purpura

,

gastroesophageal reflux

,

,

,

hematologic diseases

,

immune system diseases

,

thrombocytopenic purpura idiopathic

,

blood platelet disorders

,

autoimmune diseases

,

thrombocytopenic purpura

,

,

hemorrhagic disorders

,

skin manifestations

,

knee osteoarthritis

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use